27
total announcements
WINDLAS.NS · 15 min delayed
Key Stats · Yahoo Finance · as of 20 Oct 2026
Market Cap
₹1,870 Cr
P/E (TTM)
29.0
EPS (TTM)
₹31.26
52W Low
₹697.40
52W High
₹1,181.90
Dividend Yield
0.69%
Beta
0.26
Price / Book
3.3
Debt / Equity
6.1
Revenue (TTM)
₹942 Cr
Gross Margin
37.98%
Operating Margin
7.85%
Windlas Biotech Limited
Windlas Biotech Limited has announced the record date for the purpose of dividend for the financial year 2025-26 as July 16, 2026, and has recommended a dividend of Rs. 6.30 per equity share.
Windlas Biotech Limited
Windlas Biotech Limited has informed the Exchange about the publication of a newspaper advertisement for its 25th Annual General Meeting (AGM) to be held on July 23, 2026, through video conferencing.
Windlas Biotech Limited
Windlas Biotech Limited has informed the Exchange about Credit Rating reaffirmed by ICRA Limited for various facilities of the Company.
Windlas Biotech Limited
Windlas Biotech Limited has informed the Exchange about a scheduled analyst/institutional investor meeting on July 7, 2026, where the company will discuss publicly available documents and no unpublished price-sensitive information will be shared.
Windlas Biotech Limited
Windlas Biotech Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015, from July 1, 2026, till the expiry of 48 hours after the unaudited financial results of the Company for the quarter ended June 30, 2026, becomes generally available information.
Windlas Biotech Limited
Windlas Biotech Limited has informed the Exchange about the schedule of analyst/institutional investor meetings under the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015.
Windlas Biotech Limited
Windlas Biotech Limited has informed the Exchange about the schedule of an analyst/institutional investor meeting, which will be held on July 2, 2026, and will refer to publicly available documents.